Pipeline of Drug Candidates

ContraVir is developing drug candidates for expanding market segments with high unmet need.

Preclinical

Phase 1

Phase 2

Phase 3

Hepatitis B

Phase 2a

75%

Hepatitis B

Phase 1

36%